Table:
begin	end	state
1	20	cytoplasmic
21	42	transmembrane
43	52	non-cytoplasmic
53	73	transmembrane
74	91	cytoplasmic
92	117	transmembrane
118	149	non-cytoplasmic
150	170	transmembrane
171	180	cytoplasmic
181	201	transmembrane
202	207	non-cytoplasmic
208	230	transmembrane
231	249	cytoplasmic
250	273	transmembrane
274	296	non-cytoplasmic
297	324	transmembrane
325	346	cytoplasmic
347	366	transmembrane
367	371	non-cytoplasmic
372	391	transmembrane
392	402	cytoplasmic
403	423	transmembrane
424	428	non-cytoplasmic
429	447	transmembrane
448	461	cytoplasmic

Input:
>WP_012991424.1 NCBI__GCF_000025605.1:WP_012991424.1
MDLLRRKCYTVEEGKLVRKLGVVDLVALGIGGIIGAGIFVITGKVAHAYAGPGIVLAFLL
CAVVVGISAFIYAELSTAYPISGSAYSYTYATVGEFVAWLVAWNLIVEYGVATAAVATGW
SGYMRTLLKENLGLELPTFLSGPFNLEKGTFIDLLAFLALVAVFLLLTVGIKESATVNNI
MVGIKLITLLVFVVFGLPHINFDNLNPFLPYGLTGVWHAASMIIFAYLGFDAVSTVAEEA
KDPKRTLPAGLILSLAISTALYIVVSFTLVGMVNYKELNVPDALAYAMFRTGNHTLGSLI
ATGAIITITSVMIVMGLGFTRVVFALSRDGLLPLWLSEVHPRFRTPYRATLLGGLVISLL
GGFLPLEDLAKLVNIGTLFAYFWVAVGLILLRWRGDAEPTFKLPAAWFFVPLNMALLLFV
MAGLGKETWVRFLLWNLLGLVIYFFYGYRNSRYYERTPAEM

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server